Home
NewsNewsKindbody and Future Family partner to expand access to fertility care through flexible financing and personalised clinical support. Offering up to $50,000 in funding, concierge guidance, and inclusive services, the collaboration helps reduce financial barriers, enabling more individuals and families to pursue IVF and other reproductive treatments with confidence.
Kindbody, a leading fertility and family-building benefits provider and clinical care delivery platform, has announced a landmark partnership with Future Family, the premier financing platform designed exclusively for fertility patients. This collaboration is specifically designed to Expand Access to Fertility Care by providing patients with flexible, patient-centred financing options integrated with dedicated clinical and financial support.
The partnership addresses a significant challenge in the reproductive health sector: the high cost of treatment. With the average IVF cycle costing between $15,000 and $20,000 and many patients requiring multiple cycles, financial barriers often prevent individuals from pursuing their dreams of parenthood. By joining forces, Kindbody and Future Family aim to alleviate this burden through comprehensive financial solutions and expert guidance.
“Access to affordable, compassionate fertility care has been our mission since day one,” said Brian Miller, Chief Operating Officer at Kindbody. “Partnering with Future Family allows us to remove one of the most significant barriers our patients face—the cost of treatment. Together, we're ensuring that financial constraints don't stand between people and their dreams of building a family.”
Through this initiative to Expand Access to Fertility Care, Kindbody patients can now access personalised financing of up to $50,000 with competitive rates and flexible terms tailored to individual treatment plans. The platform offers a soft pre-qualification process that does not impact credit scores, allowing patients to explore their options with peace of mind.
Beyond the financial aspect, the partnership provides a "concierge" approach to care. Patients are paired with dedicated Financial Specialists to customise payment plans and RN Care Coaches who provide expert clinical guidance throughout the journey. The coverage is inclusive, encompassing IVF, IUI, egg freezing, medications, genetic testing, and donor services.
Claire Tomkins, Founder of Future Family, founded the platform based on her own struggles with the high out-of-pocket costs of IVF. She noted, “Future Family was born from personal experience—I built my own family through IVF and experienced first hand the high out of pocket cost of IVF. Financial stress can compound an already emotional journey. We've helped more than 10,000 patients move forward with care, and partnering with Kindbody allows us to extend that support to even more families seeking compassionate, accessible fertility treatment.”
This collaboration reflects a shared commitment to making family building more equitable. The services are designed to Expand Access to Fertility Care for a diverse range of patients, including LGBTQ+ individuals, single parents by choice, and anyone facing fertility challenges. Future Family's financing features, such as no prepayment penalties and interest that accrues only on funds used, ensure that the process is as transparent and manageable as possible.
Kindbody continues its mission to democratise women’s health and reproductive care through its national network of signature clinics and virtual care options. Together with Future Family’s specialised financing, they are removing the financial barriers that stand in the way of building the families of the future. Patients can begin the process by applying for financing online to explore options specific to their unique treatment timelines.
As more families pursue fertility treatments, IVF CRYO urges greater transparency and safety in better Safe Embryos and Eggs Shipping across the U.S.
China sees a rise in advanced maternal age In Vitro Fertilization, driven by BaseCare Medical’s AI undisturbed culture system that improves embryo quality and clinical pregnancy rates, especially with PGT. Localized AI-assisted solutions position BaseCare as a leader in smart, precision reproduction technology for older IVF patients.
According to a landmark large-scale IVF trial, using natural ovulation for frozen embryo transfers achieves matching birth rates to standard hormone cycles, offering a safer alternative for women.
IVI RMA North America has launched the IVI RMA Patient Advisory Council in the US and Canada to strengthen patient-centered care. The councils bring patients, clinicians, and leadership together in structured monthly discussions, ensuring real patient experiences inform fertility care improvements, service innovation, and long-term clinical strategies.
Conceivable Life Sciences' AURA, world's first AI-powered automated IVF lab, has successfully delivered 18 healthy babies since April 2025. The revolutionary robotic system automates 200+ IVF steps with unprecedented precision, promising to make fertility treatment more accessible, affordable, and consistent while eliminating human error in embryo creation.
Infertility Treatment Drugs from Merck have enabled the births of 6 million babies globally, with 50% of conceived individuals tied to its therapies.
EMD Serono will offer steep IVF drug discounts via TrumpRx.gov in 2026 and seek expedited FDA review for Pergoveris, aligning with a White House order.
